They live in our houses, drink our water and even sleep in our beds. Cats have become an integral part of many households and ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic cancer.

A new study isolated DNA from the tumours of 500 cats across 13 different tumour types and mapped the sequence of 1,000 genes ...

The consideration comprises, USD200,000 paid on completion and USD400,000 set off against a subscription by Appian for 5.4 million shares at 5.5 pence each. In addition, USD1.5 million will be paid, ...

Qure shares finished the regular trading week down only 9% despite the FDA’s hard-line stance and public criticism against the company’s Huntington’s disease (HD) gene therapy candidate AMT-130.

The manuscript presents a comprehensive study on the developing synthetic gene circuits targeting mutant RAS expressing cells. The aim of this study is to use these RAS targeting circuits as cancer ...

Two companion studies published in Cancer Research from scientists at Moffitt Cancer Center identify distinct but complementary approaches to overcoming drug resistance in KRAS G12C–mutant non-small ...

Scientists have discovered new compounds that can block a key cancer-driving gene’s growth signal without harming healthy cells. Credit: Stock Scientists have developed compounds that selectively ...

Erasca, Inc. is shifting focus to novel RAS inhibitors, deprioritizing naporafenib and advancing ERAS-4001 and ERAS-0015 into early clinical trials. ERAS boasts strong liquidity with a cash runway ...